BRUKER CORP (BRKR)
About BRUKER CORP
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $3.4B
- Net income
- -$8.6M
- Total assets
- $6.2B
- Market cap
- $8.6B
- Gross margin
- 45.9%
- Operating margin
- 2.0%
- Net margin
- -0.2%
Source: SEC EDGAR · updated Jun 8, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $3.4B
- Cost of revenue
- $1.9B
- Gross profit
- $1.6B
- Operating expenses
- $1.5B
- Operating income
- $68.2M
- Income tax
- $29.3M
- Net income
- -$8.3M
- EPS (basic)
- $-0.15
- EPS (diluted)
- $-0.15
Balance sheet
- Total assets
- $6.2B
- Current assets
- $2.2B
- Total liabilities
- $3.7B
- Current liabilities
- $1.3B
- Shareholders’ equity
- $2.5B
Cash flow
- Operating cash flow
- $134.1M
- Investing cash flow
- -$196.5M
- Financing cash flow
- $135.1M
- Net cash flow
- $116.4M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $8.6B
- EPS (diluted)
- $-0.15
- Dividend yield
- 0.33%
- Shares outstanding
- 142.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 4, 2000
Bruker Corp (BRKR) Stock Price
- Reported a net loss of $8.6M in FY2025.
- Revenue grew 73% from FY2020 to FY2025.
- Gross margin of 45.9%, net margin -0.2%.
- Trading 4% below its 52-week high.
- Pays a dividend yielding about 0.33% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review BRUKER CORP.
Write a review
News about BRUKER CORP
News & sentiment via Polygon.io
Bruker Corp: frequently asked questions
Is Bruker Corp an American company?
Yes — Bruker Corp is an American company headquartered in Billerica, Massachusetts. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.
Where is Bruker Corp headquartered?
Bruker Corp is headquartered in Billerica, Massachusetts, United States.
Is Bruker Corp publicly traded?
Yes — Bruker Corp is a publicly traded company. Its stock trades under the ticker symbol BRKR on the NASDAQ.
What does Bruker Corp do?
Bruker Corp is an American Medical Devices company in the Health & Beauty sector.